Citat:
Men du hävdar ju att det är effektivt mot Covid19. Vänligen länka till en studie som är:
Tillräckligt omfattande
Har genomgått peer review
Är publicerade i en relevant och välrenommerad vetenskaplig tidskrift
Där författarens slutsatser stödjer att avlusningsmedlet är säkert och effektivt mot Covid19
Dvs. det absoluta minimum som krävs för att hävda att ett läkemedel är effektivt och säkert mot en sjukdom.
Detta har du inte kunnat göra.
Tillräckligt omfattande
Har genomgått peer review
Är publicerade i en relevant och välrenommerad vetenskaplig tidskrift
Där författarens slutsatser stödjer att avlusningsmedlet är säkert och effektivt mot Covid19
Dvs. det absoluta minimum som krävs för att hävda att ett läkemedel är effektivt och säkert mot en sjukdom.
Detta har du inte kunnat göra.
Hittade en post på reddit som beskriver läget just nu för Ivermectin. Som vanligt är det svårt veta trovärdigheten men verkar ju som om det håller på att hända saker.
"Researcher here, currently involved (and have been for a bit) in attempting to get a randomized trial of Ivermectin off the ground in SA hospitals.
Ivermectin has shown considerable promise for a while now, kicked off firstly by simulations of protein interaction which highlighted it as a strong candidate molecule and then by an in-vitro study which showed enormous anti-viral activity, albeit at concentrations higher than can be achieved in patients.
Since then, some percentage clinicians all over the world have been using it (including some right here in SA), in the face of some skepticism from a world that was burned once on HCQ. Statistical analysis of the outcomes of those clinical implementations indicated that mortality was reduced in patients given Ivermectin, but the lack of any randomization or blinding in those trials meant that those data lacked sufficient confidence for any policy implementation.
Randomized Controlled Trials (RCTs) were commissioned, and results have begun coming in. As of around mid-December, the consensus was that Ivermectin is promising but that there were was not enough evidence to act on as yet. Between then and now, a fairly solid meta-review paper has come out showing reduced mortality with fair confidence, and preprints from a couple of RCTs have had positive findings. In the last 2 weeks, the landscape on this has shifted significantly, and consensus is rapidly heading toward Ivermectin being a potential front-line treatment.
The WHO has commissioned a detailed meta-review of Ivermectin for treatment of COVID patients by Dr Andrew Hill of the University of Liverpool. Those findings, expected this month, will determine the WHO's position. In a preliminary presentation of his findings, Hill stated quite categorically that Ivermectin is effective at significantly reducing mortality, and accelerating recovery time, This being a meta-analysis across 11 trials with total of a ~1400 patients, statistical confidence is high, and the differences in outcome are staggering.
A few weeks ago, it was sort of broadly true that there wasn't enough solid evidence to support Ivermectin, it is now a near certainty that it will be recommended by the WHO as a frontline treatment before the month is out.
The SAHPRA sudden announcement of a ban of a drug that has been used safely in humans for half a century is decidedly strange. There will be rapid movement on this in the next few days."